IL247841A0
(en )
2016-11-30
Heterocyclic compounds for use in the treatment of disorders mediated by pi3k gamma
HRP20210518T1
(hr )
2021-05-14
Derivati 2,4-tiazolidindiona, namijenjeni liječenju poremećaja središnjeg živčanog sustava
EP3227330C0
(en )
2024-01-17
TDP-43 BINDING POLYPEPTIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
FI3936130T3
(fi )
2024-04-23
Valbenatsiinin annostusohjelma hyperkineettisten liikehäiriöiden hoitoon
GB201402070D0
(en )
2014-03-26
Pharmaceutical compositions for the treatment of inflammatory disorders
HK1244485A1
(zh )
2018-08-10
用於治療神經母細胞瘤的組合物
SG11201608729RA
(en )
2016-11-29
Membrane-adherent self-assembled systems for treatment of ocular disorders
DK3192524T3
(da )
2022-02-14
Hgf præparat egnet til behandling af neurologiske lidelser
PT3160464T
(pt )
2018-10-12
6-hidroxibuspirona para uso no tratamento de transtornos do movimento
SG11201708181RA
(en )
2017-11-29
Methods for the treatment of inflammatory disorders
HK1223916A1
(zh )
2017-08-11
作為用於治療神經變性疾病的神經源性藥的吡啶並 吡嗪- -甲酰胺
SG11201702700UA
(en )
2017-04-27
Methods for the treatment of peri-implantitis
MA54630A
(fr )
2021-11-03
N,n-bis-2-mercaptoéthyle isophtalamide pour le traitment des maladies neurodégénératives
TH1601002629A
(th )
2017-08-10
ไพริโด[4,3-b]ไพราซีน-2-คาร์บอกซาไมด์ ในรูปสารก่อกำเนิดประสาทสำหรับ การรักษาความผิดปกติที่มีภาวะเสื่อมของระบบประสาท
PT3370727T
(pt )
2022-04-18
Derivados da pregnenolona substituídos em c3 não bioconvertíveis para utilização no tratamento de distúrbios de toxicodependência
GB201521543D0
(en )
2016-01-20
Methods for the treatment of inflammatory disorders
ITUB20155450A1
(it )
2017-05-11
Composizione per il trattamento delle dermatiti.
GB201513993D0
(en )
2015-09-23
Methods for the treatment of inflammatory disorders
GB201513345D0
(en )
2015-09-09
Methods for the treatment of Inflammatory disorders
GB201507113D0
(en )
2015-06-10
Methods for the treatment of inflammatory disorders
GB201506419D0
(en )
2015-05-27
Methods for the treatment of inflammatory disorders
GB201506229D0
(en )
2015-05-27
Methods For the Treatment Of Inflammatory Disorders